Get a glimpse into our company and investor data—powered by the PitchBook Platform
M&ALATEST DEAL TYPE
Developer of vaccines. The company i9s engaged in the development and manufacturing of oral vaccines for human immunodeficiency virus, hepatitis B and C, influenza, tuberculosis, and bacterial and fungal infections.
Corporate Backed or Acquired
Immunitor Valuation and Funding
This information is reserved for PitchBook Platform users. To explore Immunitor‘s full profile, request access.